Artículos de revistas
Insulin Resistance/hyperinsulinemia Associated Diseases Not Included In The Metabolic Syndrome [doenças Associadas à Resistência à Insulina/hiperinsulinemia, Não Incluídas Na Síndrome Metabólica]
Registro en:
Arquivos Brasileiros De Endocrinologia E Metabologia. , v. 50, n. 2, p. 360 - 367, 2006.
42730
10.1590/S0004-27302006000200022
2-s2.0-33744482612
Autor
Carvalheira J.B.C.
Saad M.J.A.
Institución
Resumen
In the past years, in Brazil and in developed countries, obesity has become a major public health problem. It was identified that besides DM2 and metabolic syndrome other clinical entities were associated with insulin resistance. In this review we describe some of these alterations emphasizing nonalcoholic fatty liver disease, but also including polycistic ovary disease, hyperuricemia, chronic renal failure, heart failure, cognitive decline and cancer. 50 2 360 367 Sheth, S.G., Gordon, F.D., Chopra, S., Nonalcoholic steatohepatitis (1997) Ann Intern Med, 126, pp. 137-145 Angulo, P., Nonalcoholic fatty liver disease (2002) N Engl J Med, 346, pp. 1221-1231 Sass, D.A., Chang, P., Chopra, K.B., Nonalcoholic fatty liver disease: A clinical review (2005) Dig Dis Sci, 50, pp. 171-180 Carvalheira, J.B., Ribeiro, E.B., Folli, F., Velloso, L.A., Saad, M.J., Interaction between leptin and insulin signaling pathways differentially affects JAK-STAT and PI 3-kinase-mediated signaling in rat liver (2003) Biol Chem, 384, pp. 151-159 Uygun, A., Kadayifci, A., Yesilova, Z., Erdil, A., Yaman, H., Saka, M., Serum leptin levels in patients with nonalcoholic steatohepatitis (2000) Am J Gastroenterol, 95, pp. 3584-3589 Chitturi, S., Farrell, G., Frost, L., Kriketos, A., Lin, R., Fung, C., Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity? (2002) Hepatology, 36, pp. 403-409 Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J., Cummings, O.W., Design and validation of a histological scoring system for nonalcoholic fatty liver disease (2005) Hepatology, 41, pp. 1313-1321 Neuschwander-Tetri, B.A., Brunt, E.M., Wehmeier, K.R., Oliver, D., Bacon, B.R., Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPARg ligand rosiglitazone (2003) Hepatology, 38, pp. 1008-1017 Promrat, K., Lutchman, G., Uwaifo, G.I., Freedman, R.J., Soza, A., Heller, T., A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis (2004) Hepatology, 39, pp. 188-196 Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Zoli, M., Melchionda, N., Metformin in non-alcoholic steatohepatitis (2001) Lancet, 358, pp. 893-894 Sanyal, A.J., Mofrad, P.S., Contos, M.J., Sargeant, C., Luketic, V.A., Sterling, R.K., A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis (2004) Clin Gastroenterol Hepatol, 2, pp. 1107-1115 Abdelmalek, M.F., Angulo, P., Jorgensen, R.A., Sylvestre, P.B., Lindor, K.D., Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: Results of a pilot study (2001) Am J Gastroenterol, 96, pp. 2711-2717 Dunaif, A., Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis (1997) Endocr Rev, 18, pp. 774-800 Nestler, J.E., Jakubowicz, D.J., Evans, W.S., Pasquali, R., Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome (1998) N Engl J Med, 338, pp. 1876-1880 Carvalho, C.R., Carvalheira, J.B., Lima, M.H., Zimmerman, S.F., Caperuto, L.C., Amanso, A., Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: Activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways (2003) Endocrinology, 144, pp. 638-647 Wyngaarden, J.B., Kelley, W.N., Gout (1983) Metabolic Basis of Inherited Disease. 5th Ed., p. 1043. , New York: McGraw-Hill Zavaroni, I., Mazza, S., Fantuzzi, M., Dall'Aglio, E., Bonora, E., Delsignore, R., Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia (1993) J Intern Med, 234, pp. 25-30 Chen, J., Muntner, P., Hamm, L.L., Jones, D.W., Batuman, V., Fonseca, V., The metabolic syndrome and chronic kidney disease in US adults (2004) Ann Intern Med, 140, pp. 167-174 Jones, C.A., Francis, M.E., Eberhardt, M.S., Chavers, B., Coresh, J., Engelgau, M., Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey (2002) Am J Kidney Dis, 39, pp. 445-459 Palaniappan, L., Carnethon, M., Fortmann, S.P., Association between microalbuminuria and the metabolic syndrome: NHANES III (2003) Am J Hypertens, 16, pp. 952-958 Clausen, P., Jensen, J.S., Jensen, G., Borch-Johnsen, K., Feldt-Rasmussen, B., Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects (2001) Circulation, 103, pp. 1869-1874 Kambham, N., Markowitz, G.S., Valeri, A.M., Lin, J., D'Agati, V.D., Obesity-related glomerulopathy: An emerging epidemic (2001) Kidney Int, 59, pp. 1498-1509 Cohen, A.H., Massive obesity and the kidney. A morphologic and statistical study (1975) Am J Pathol, 81, pp. 117-130 Ingelsson, E., Sundstrom, J., Arnlov, J., Zethelius, B., Lind, L., Insulin resistance and risk of congestive heart failure (2005) JAMA, 294, pp. 334-341 Burchfiel, C.M., Skelton, T.N., Andrew, M.E., Garrison, R.J., Arnett, D.K., Jones, D.W., Metabolic syndrome and echocardiographic left ventricular mass in blacks: The Atherosclerosis Risk in Communities (ARIC) Study (2005) Circulation, 112, pp. 819-827 Carvalheira, J.B., Calegari, V.C., Zecchin, H.G., Nadruz Jr., W., Guimarães, R.B., Ribeiro, E.B., The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: Implications for insulin resistance (2003) Endocrinology, 144, pp. 5604-5614 Carvalho, C.R., Thirone, A.C., Gontijo, J.A., Velloso, L.A., Saad, M.J., Effect of captopril, losartan, and bradykinin on early steps of insulin action (1997) Diabetes, 46, pp. 1950-1957 Yaffe, K., Kanaya, A., Lindquist, K., Simonsick, E.M., Harris, T., Shorr, R.I., The metabolic syndrome, inflammation, and risk of cognitive decline (2004) JAMA, 292, pp. 2237-2242 Calle, E.E., Kaaks, R., Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms (2004) Nat Rev Cancer, 4, pp. 579-591 (2002) IARC Handbooks of Cancer Prevention, Weight Control and Physical Activity, , Lyon: International Agency for Research on Cancer